Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Providers
March 23, 2013 12:00 AM

Doctor-approved

As health apps flourish, hospitals are beginning to sanction some for patients

Jaimy Lee
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    AliveCor's mobile heart monitor was approved by the FDA in December.

    Some hospitals are beginning to develop formulary-like lists of smartphone and tablet applications acceptable for use in clinical settings as more patients and physicians incorporate medical apps into their care regimens.

    Carolinas HealthCare System, which owns, leases or manages 23 hospitals in North and South Carolina, and St. Luke's Episcopal Health System, a six-hospital system based in Houston, are both forming “app formularies” that will utilize an app certification program. The program was created by Happtique, a mobile health apps marketplace owned by GNYHA Ventures, the for-profit arm of the Greater New York Hospital Association.

    “We can provide some system-level evaluation and structure to help both providers and patients make sense of the complex world of mobile health,” said Dr. Gregory Weidner, medical director of primary-care innovation and proactive health for Charlotte, N.C.-based Carolinas HealthCare System.

    An estimated 40,000 health and wellness mobile apps are now on the market, a number that is growing at a rapid clip. Yet only about 25 have received clearance from the Food and Drug Administration. The vast majority are unregulated.

    Many apps, including the ones that do not require FDA clearance, are starting to be used by hospitals and physicians seeking to improve care management of their patients, including those who are chronically ill. This growing use has raised unanswered questions about whether there is clinical benefit, how they should be regulated and how the apps are reimbursed.

    That has led organizations like Happtique and its health system collaborators to step into the breach in an effort to come up with answers. Carolinas is putting together a pilot program that will provide Type 2 diabetes patients with access to a suite of 15 apps and digital tools that are expected to help them manage their diabetes and overall health. The system is developing an app formulary specifically for the six- to nine-month program, Weidner said.

    “If the potential of mobile health is recognized, that will allow us to provide new ways to partner with and interact with our patients,” he said.

    The formularies being developed by Carolinas and St. Luke's Episcopal will include apps that require federal oversight and those that do not.

    WellDoc, a Baltimore-based technology firm, developed a mobile diabetes-management system that was one of the first of its kind to be cleared by the FDA in 2010.

    The company chose to pursue the federal review process because it expected the FDA to eventually regulate the sector, said Demir Bingol, WellDoc's vice president of commercial marketing and commercial development.

    “We wanted to take the higher standard because we thought it was important for patients,” he added.

    WellDoc is preparing for a commercial launch of the product, which will then make it available by prescription. The system is now available to physicians. The company is also in discussions with payers about getting reimbursed for the system.

    However, some app developers, investors and lawmakers say the burgeoning mobile health market has been held back by a lack of clarity from federal authorities about how they plan to regulate medical mobile apps. The FDA didn't issue draft guidance on its plans for regulating mobile medical apps until mid-2011.

    The delay in issuing final guidance has drawn criticism from lawmakers and mobile app developers. Several testified at a House subcommittee hearing last week about the regulatory uncertainty and its impact on the market. “It's sort of created this little stalemate,” said Happtique CEO Ben Chodor. Developers “can't go to insurance companies saying, 'This should be reimbursable.'”

    The FDA has promised to release the guidance by Oct. 1. An FDA official told lawmakers that the agency plans to focus on “higher-risk products” rather than low-risk technologies, such as apps that monitor the number of steps a patient takes each day or remind a patient to refill a prescription.

    Some lawmakers are pushing legislation that would beef up the FDA's ability to oversee the medical app field. Rep. Mike Honda (D-Calif.), who represents Silicon Valley, plans to reintroduce a bill that would require the FDA to establish an office of wireless health technology as part of a broader effort to spur mobile health and health technology innovation and adoption. The bill will be reintroduced in April, a spokesman for Honda's office said.

    As more Americans acquire smartphones and tablets, the expectation is that patients will increasingly seek out mobile medical apps that they plan to use as part of their personal healthcare. In some instances, patients are asking physicians whether they should use a particular app. In others, physicians are prescribing and recommending apps.

    Patients, facing rising healthcare costs, may opt for an app that is free or costs much less than a $25 or $50 copayment for a doctor's visit. A recent study questioned the impact of certain apps developed for diagnosis.

    The study, published in January in JAMA Dermatology, found that 3 out of 4 smartphone apps used to detect melanomas incorrectly defined 30% of melanomas as insignificant. One app missed 93% of all melanomas. None of the apps received FDA clearance.

    Dr. Laura Ferris, a co-author of the study, said the results raised questions about how these apps are regulated, especially those developed to provide clinical information for a cancerlike melanoma. Delays in detection and removal can dramatically affect how long a patient will live. A patient's decision to buy a 99-cent app as opposed to paying a $50 copay for an office visit could have negative health consequences, she noted.

    “People may be lulled into the idea that it's so technologically advanced and fancy,” Ferris said. “The technology has outpaced regulatory oversight.”

    AliveCor, a San Francisco-based medical technology company, decided to seek FDA clearance for its mobile heart monitor, which it received in December. The device enables an ECG device's electronic monitors to be linked to a smartphone that has an app to record the signal.

    Before the review process, the company considered whether the combination device was, in fact, a medical device. AliveCor executives knew the device would be used in a clinical setting to assist physicians with diagnoses rather than as a tool for patients to track and monitor their heart health.

    “We did ask that question: Are we a medical device?” said Michael Righter, AliveCor's director of regulatory affairs. “It's very clear that what we have in our hands is a medical device.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    mh-20250513-Yellowstone-rural
    How 24 rural hospitals look to improve value-based care
    mh-20250509-dementia
    Federal dementia pilot has rocky rollout for some providers
    Most Popular
    1
    UnitedHealth Group to cut Medicare drug plan commissions
    2
    PBM limits could finally pass, if Congress moves its tax-cut bill
    3
    ACOs call on Oz to fix Shared Savings Program benchmarking issue
    4
    Where top executive search firms are seeing changes in demand
    5
    Investors welcome a maturing digital health market
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content